Advertisement

Topics

Hikma risks a stratospheric 430% price increase on product

05:09 EDT 22 Aug 2017 | Pharmafile

It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series of price gauging stories has put an end to that era and now companies are under much more pressure to be both transparent over their price increases, with more now committing to ensuring they keep annual price increase within 10%.

read more

Original Article: Hikma risks a stratospheric 430% price increase on product

NEXT ARTICLE

More From BioPortfolio on "Hikma risks a stratospheric 430% price increase on product"

Advertisement
Quick Search
Advertisement
Advertisement